BCAX Stock-Based Compensation
Bicara Therapeutics Inc · Stock-Based Compensation
BCAX Stock-Based Compensation
Latest reported$22.16Mperiod ending
BCAX TTM Stock-Based Comp ($1.90M → $22.16M)
TTM stock-based compensation
High-resolution chart · PNG
BCAX stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 22,159,000 | |
| 17,413,000 | |
| 15,006,000 | |
| 13,738,000 | |
| 12,155,000 | |
| 9,701,000 | |
| 7,397,000 | |
| 4,981,000 | |
| 3,469,000 | |
| 2,738,500 | |
| 1,899,000 |